TARIS Biomedical Appoints Christopher Searcy as the Company’s Chief Business Officer

Published: Jul 25, 2011

LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS Biomedical®, a specialty pharmaceutical company pioneering the development of innovative, targeted therapies using drug delivery to treat bladder diseases, announced today that Dr. Christopher Searcy has joined the company as its Chief Business Officer and Senior VP of Corporate Development. In this role he will have global responsibility for the business strategy for TARIS including corporate partnerships and other strategic alliances involving the company’s products and technologies.

Back to news